Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Fresenius Kabi EspañaFresenius Kabi España
VS
Dr. Reddy's LaboratoriesDr. Reddy's Laboratories
Fresenius Kabi España

Fresenius Kabi España

Carrer de la Marina, 16, Barcelona, 08005, ES

Last Update: 11/12/2025

View Profile
753/1000Fair

Fresenius Kabi es una empresa de asistencia sanitaria que tiene como objetivo ofrecer a los profesionales sanitarios la mejor solución posible a los retos a los que se enfrentan a diario, a través del suministro de productos y servicios para centros hospitalarios, así c...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:181
Subsidiaries:38
12-month incidents
0
Known data breaches
0
Attack type number
0
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TS, IN, 500034

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.drreddys.com
783/1000Fair

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including AP...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:31,653
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Fresenius Kabi España

Fresenius Kabi España

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi España in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Dr. Reddy's Laboratories in 2026.

Incidents

Incident History - Fresenius Kabi España (X = Date, Y = Severity)

Fresenius Kabi España cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Dr. Reddy's Laboratories (X = Date, Y = Severity)

Dr. Reddy's Laboratories cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Fresenius Kabi España

Fresenius Kabi España

Incidents
No explicit notable incidents reported.
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Incidents
No explicit notable incidents reported.

FAQ

Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has the best AI Cybersecurity Score ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced more cyber incidents in the past ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced more cyber incidents this year ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced at least one ransomware attack ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced at least one data breach ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced at least one targeted cyberattack ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has experienced at least one vulnerability ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one holds the most compliance certifications ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one holds the fewest compliance certifications ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has the most subsidiaries ?
Between Fresenius Kabi España company and Dr. Reddy's Laboratories company, which one has the largest number of employees ?
Between Fresenius Kabi España and Dr. Reddy's Laboratories, which company holds both SOC 2 Type 1 certifications ?
Between Fresenius Kabi España and Dr. Reddy's Laboratories, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Fresenius Kabi España or Dr. Reddy's Laboratories ?
Which company is PCI DSS compliant - Fresenius Kabi España or Dr. Reddy's Laboratories ?
Between Fresenius Kabi España and Dr. Reddy's Laboratories, which company complies with HIPAA regulations for healthcare data ?
Between Fresenius Kabi España and Dr. Reddy's Laboratories, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-50044
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-44955
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-42933
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 10.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.9
CVE-2026-40430
SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-28698
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 8.6)
CVSS3
Base Score: 8.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 9.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
3.9